Pharma 4.0: Analytical Procedure Lifecycle Management

by | Nov 18, 2021

Applying an enhanced approach to the lifecycle of analytical procedures from development through validation will be discussed.

In this forum, the expert panel will discuss applying an enhanced approach to the lifecycle of analytical procedures from development through validation, transfer, operational execution, and change control until final discontinuation.

Pharma4_WebHeader_OND

Technology, Innovation & Impact on the Laboratory
REGISTER TO ATTEND THIS EDUCATIONAL EVENT

Separation Science, in collaboration with Thermo Fisher Scientific, brings the 2021 instalment of PHARMA 4.0: Transforming Pharmaceutical Manufacturing, an eConference and Expert Discussion Forums Series with eminent global thought leaders that covers current and future trends in analytical, process, quality and regulatory issues and their impact on the laboratory of the future and its connection to continuous manufacturing.

PHARMA 4.0: Transforming Pharmaceutical Manufacturing brings together participants from industry, academia and regulatory to create an invaluable resource for recent developments, future trends, challenges and solutions for the development & manufacturing of pharmaceutical & biotechnology products.

Analytical Procedure Lifecycle Management

GeraldGellermanGerald Gellerman - Senior Fellow
Novartis, Switzerland

ManojMettaWebDr Manoj Kumar Metta - Science and Standards Liaison - Global Biologics
United States Pharmacopeia, India

PhilNethercotePhil Nethercote - Independent consultant in Pharmaceutical Analysis
UK

FrankSteinerFrank Steiner - Senior Manager Product Applications
Thermo Fisher Scientific, Germany

PatrickJacksonPatrick Jackson - Investigator
GSK, UK

 

JapanFlag_Final全てのeConferenceとフォーラムで、日本語字幕をご利用いただけます。

SouthKoreaFlag_Final모든 온라인 컨퍼런스 및 포럼에는 한국어 자막이 제공됩니다.

FlagTaiwan線上論壇及圓桌論壇講師將以英文簡報,並有繁體中文字幕。

 

 

Related Content

Advertisment

Advertisment

Advertisement